Abstract
As an immune-mediated demyelinating disease, could multiple sclerosis (MS) be treated by myeloablative therapy followed by bone marrow transplantation? Richard Burt and colleagues discuss preliminary data on this approach in the MS model of experimental allergic encephalomyelitis and in MS patients.
Original language | English (US) |
---|---|
Pages (from-to) | 559-561 |
Number of pages | 3 |
Journal | Immunology Today |
Volume | 18 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1997 |
ASJC Scopus subject areas
- Immunology